PROUVE CEDRIC 4

Accession 0001001250-21-000028

CIK 0001001250other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:03 PM ET

Size

24.0 KB

Accession

0001001250-21-000028

Form 4

Period: 2021-02-24

Group President, International

Transactions

Exercise/Conversion
Class A Common Stock
2021-02-24$107.95/sh+18,410$1,987,360→ 255,929 total
Exercise/Conversion
Class A Common Stock
2021-02-24$138.15/sh+4,029$556,606→ 259,958 total
Sale
Class A Common Stock
2021-02-24$295.68/sh−13,509$3,994,341→ 246,449 total
Sale
Class A Common Stock
2021-02-24$296.51/sh−7,580$2,247,546→ 238,869 total
Sale
Class A Common Stock
2021-02-24$297.20/sh−1,350$401,220→ 237,519 total
Exercise/Conversion
Class A Common Stock
2021-02-25$138.15/sh+4,967$686,191→ 242,486 total
Sale
Class A Common Stock
2021-02-25$292.27/sh−4,816$1,407,572→ 237,670 total
Sale
Class A Common Stock
2021-02-25$293.01/sh−150$43,952→ 237,520 total
Sale
Class A Common Stock
2021-02-25$293.12/sh−1$293→ 237,519 total
Exercise/Conversion
Option (right to buy)
2021-02-24−18,410→ 0 total
Exercise: $107.95From: 2019-01-01Exp: 2027-09-05→ Class A Common Stock (18,410 underlying)
Exercise/Conversion
Option (right to buy)
2021-02-24−4,029→ 22,133 total
Exercise: $138.15From: 2020-01-01Exp: 2028-09-04→ Class A Common Stock (4,029 underlying)
Exercise/Conversion
Option (right to buy)
2021-02-25−4,967→ 17,166 total
Exercise: $138.15From: 2020-01-01Exp: 2028-09-04→ Class A Common Stock (4,967 underlying)

Footnotes (8)

[F1]Stock Options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 18,409 shares exercisable from and after January 1, 2019; 18,410 shares exercisable from and after January 1, 2020 and 18,410 shares exercisable from and after January 1, 2021.
[F2]Stock Options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 13,080 shares exercisable from and after January 1, 2020; 13,081 shares exercisable from and after January 1, 2021 and 13,081 shares exercisable from and after January 1, 2022.
[F3]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
[F4]Sales prices range from $295.04 to $296.03 per share, inclusive.
[F5]Sales prices range from $296.05 to $297.04 per share, inclusive.
[F6]Sales prices range from $297.07 to $297.75 per share, inclusive.
[F7]Sales prices range from $292.00 to $292.89 per share, inclusive.
[F8]Not Applicable

Documents

1 file

ESTEE LAUDER COMPANIES INC

CIK 0001001250

Entity typeother